Pharma/Biopharma Archives - Oxford University Innovation

Oxford Classic – a novel prognostic signature to predict outcome in ovarian cancer patients

Next-generation ovarian cancer solution: innovative biomarker technology enabling early detection, precise diagnosis, and personalised treatment plan development for improved outcomes in high-grade serous ovarian carcinoma (HGSOC)

MuSpAn – Multiscale Spatial Analysis Toolbox

MuSpAn is a multiscale spatial analysis toolbox designed by mathematicians to assist biologists in analysing complex imaging data.

BioPatch – a bio-instructive resorbable implant for enhancing surgical repair of rotator cuff tendon

BioPatch aids rotator cuff repair with strength and bioactive support.

A scalable mRNA synthesis platform for manufacturing mRNAs with batch consistency and high translational output

Designer Cytotoxic T cells: Transcription Factor-Based Engineering with FOSL1

Designer Cytotoxic T cells: Method to enhance persistence and cytotoxicity of T-Cell adoptive therapies.

Enhanced Discriminatory Receptors (EDR) – enhancing discriminatory power of T cells

Enhanced Discriminatory Receptors (EDR) - enhancing discriminatory power of T cells

Production of T cells with enhanced antigen discrimination power

Methods to enhance discriminatory power of T Cell

Adenovirus-vectored vaccine manufacturing production and purification process

Improved methods of manufacturing and purification processes for adenoviral vectored vaccines, oncolytic viruses and gene therapies to high Titre, with low cost of goods.

Method to generate human bone organoid

A method for generating ex vivo models of the bone and bone marrow, which involves the use of a fragmented gel as a 3D scaffold to drive vascularisation and differentiation.

Rhodium catalysed cross-coupling approach to enantioenriched piperidines

Novel method to access enantioenriched dihydropyridines - these dihydropyridines are precursors to chiral piperidines known for diverse biological activities.

Ready to get in touch?